GRI BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards
GRI BIO, INC. (GRI) had Deferred Tax Assets, Operating Loss Carryforwards of $16.78 million as of 2025-12-31, per its 10-K filed 2026-01-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-01-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.78M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $14.54M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.85M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.21M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $16.78M 10-K · filed 2026-01-30 |
| 2024-12-31 | $14.54M 10-K · filed 2026-01-30 |
| 2023-12-31 | $12.85M 10-K · filed 2025-03-14 |
| 2022-12-31 | $3.21M 10-K · filed 2024-03-28 |